Issue of Securities pursuant to Rights Issue.

Fund Raising View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.1%Reaction day

₹77.87

prior close

₹78.13

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+2.4%-3.5% vs market

Other Financial Services peers, median of 82sector+0.0%-1.1% vs sector

On the reaction day the stock moved 3.5 pts less than Nifty Microcap 250 and 1.1 pts less than its Other Financial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.8

10m

+2.4

15m

+1.7

30m

+2.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.1+2.4-3.5+0.0-1.1

Next day

-1.0-0.5-0.5-2.6+1.6

+5.0-3.4+8.4-4.1+9.2

+2.7+1.1+1.6-0.3+3.0

+2.7+1.8+1.0+0.5+2.2

+6.6+2.8+3.7+0.5+6.1

+15.4+7.5+7.9+5.9+9.5

15d

+44.9+15.7+29.2+10.0+34.9

+41.7+18.0+23.6+10.4+31.3

+28.4+20.9+7.6+10.6+17.8

+65.7+27.6+38.0+10.5+55.1

UpDownMarket · Nifty Microcap 250Sector · Other Financial Services peers, median of 82Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Nexome Capital Markets Ltd (formerly SMIFS Capital Markets) has completed its Rights Issue, which opened on March 13, 2026 and closed on March 23, 2026. The issue was oversubscribed by 100.79%, with the total issue size being Rs. 22.04 crore. The company has allotted 29,38,500 fully paid-up equity shares at Rs. 75 per share (including a Rs. 65 share premium over the Rs. 10 face value). Post-allotment, the paid-up equity share capital stands at Rs. 8.82 crore, comprising 88,15,500 shares.

Likely market impact

The strong oversubscription reflects solid investor demand and confidence in the company. The infusion of Rs. 22+ crore will strengthen the company's capital base, though existing shareholders also had to contribute additional capital to maintain their stake.